Results 141 to 150 of about 677,891 (339)

A spectrophotometric determination of sphingosine

Journal of Lipid Research, 1962
Carl J. Lauter, Eberhard G. Trams
doaj   +1 more source

Correction: Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study

, 2019
Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai∥, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi∥   +12 more
openalex   +1 more source

Oxide Liner, Barrier and Seed Layers, and Cu Plating of Blind Through Silicon Vias (TSVs) on 300 mm Wafers for 3D IC Integration [PDF]

, 2012
Chien-Ying Wu, Shang-Chun Chen, Pei-Jer Tzeng, John H. Lau, Y. Y. Hsu, Jui‐Chin Chen, Yu-Chen Hsin, Chien‐Chou Chen, Shang-Hung Shen, Cha-Hsin Lin, Tzu-Kun Ku, Ming‐Jer Kao   +11 more
openalex   +1 more source

Comment on: Fibrinogen Changes Before and After Intravenous Thrombolysis as Predictors of Cerebral Injury and Clinical Outcomes in Acute Ischemic Stroke—The 24‐h Time‐Point May be a Pro‐Thrombotic Blind Spot: Check 6‐h Fibrinogen Rebound to Catch Early Re‐Occluders

Annals of Clinical and Translational Neurology, EarlyView.
Qichao Fang, Luting Ying, Yongjin Gong
wiley   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

EFFICACY AND SAFETY OF STANDARDIZED CINNAMON BARK EXTRACT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED WEIGHT LOSS AND ALOPECIA IN PATIENTS WITH BREAST CANCER: A RANDOMIZED, DOUBLE-BLIND, AND PLACEBO-CONTROLLED STUDY

, 2019
Ajay Mehta, Suchitra Ajay Mehta, Prasad Thakurdesai   +2 more
openalex   +2 more sources

NIGHT BLINDNESS [PDF]

British Journal of Ophthalmology, 1939
openaire   +2 more sources

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Non-communicable eye diseases: facing the future

Community Eye Health Journal, 2014
The World Health Assembly, which met in May 2013, adopted a new global programme document entitled ‘Universal eye health: a global action plan 2014–2019′.
Serge Resnikoff, Ivo Kocur
doaj  

A response to ‘Acupuncture compared to placebo‐acupuncture for postoperative nausea and vomiting prophylaxis: A randomised placebo‐controlled patient and observer blind trial’, Streitberger K, Diefenbacher M, Bauer A et al . Anaesthesia 2004; 59: 142–9 [PDF]

, 2004
H. Lee
openalex   +1 more source